Acort (isoconazole Nitrate + Diflucortolome Valerate)
Net Weight: 19g
Shelf Life: 3 Years
The treatment of limited skin mycoses is not generallycomplicated, in view of the diverse range of modernanti-fungal products available for external use.1–3While they may be effective for some patients, topicalanti-fungal agents may aggravate an inﬂammatoryprocess, which is manifested by the intensiﬁcation ofpruritus, hyperaemia, exudation and the appearanceof vesiculation and weeping. This may occur for tworeasons: ﬁrst, the causative agents of skin mycoses arenot very sensitive to the prescribed anti-fungal agent;second, if the mycotic process has an acute coursewith a marked exudative reaction, then prescribingeven an effective anti-fungal agent may result inintensiﬁcation of manifestations of an inﬂammatoryprocess. This occurs most commonly in patientssuffering from chronic skin diseases and in patientspredisposed to allergic reactions. In such cases, theanti-inﬂammatory activity of an anti-fungal productfor topical use is found to be inadequate and there isa need to prescribe combined products containinganti-fungal agents and glucocorticosteroids.